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1764 | Analyst, 2013, 138, 1764–177Microspectroscopic SERS detection of interleukin-6 with
rationally designed gold/silver nanoshells†
Yuling Wang, Mohammad Salehi, Max Schu¨tz, Katharina Rudi
and Sebastian Schlu¨cker*
Rationally designed gold/silver nanoshells (Au/Ag-NS) with plasmon resonances optimized for red laser
excitation in order to minimize autofluorescence from clinical samples exhibit scattering cross-sections,
which are ca. one order of magnitude larger compared with solid quasi-spherical gold nanoparticles
(Au-NPs) of the same size. Hydrophilic stabilization and sterical accessibility for subsequent
bioconjugation of Au/Ag-NS is achieved by coating their surface with a self-assembled monolayer
(SAM) of rationally designed Raman reporter molecules comprising terminal mono- and tri-ethylene
glycol (EG) spacers, respectively. The stability of the hydrophilically stabilized metal colloid was tested
under different conditions. In contrast to metal colloids coated with a SAM without terminal EG spacers,
the hydrophilically stabilized SERS particles do not aggregate under physiologically relevant conditions,
i.e., buffer solutions with high ionic strength. Using these rationally designed SERS particles in
conjunction with a microspectroscopic acquisition scheme, a sandwich immunoassay for the sensitive
detection of interleukin-6 (IL-6) was developed. Several control experiments demonstrate the high
specificity of the assay towards IL-6, with a lowest detectable concentration of ca. 1 pg mL1. The signal
strength of the Au/Ag-NS is at least one order of magnitude higher compared with hydrophilically
stabilized, non-aggregated solid quasi-spherical Au-NPs of the same size.Introduction
Surface enhanced Raman scattering (SERS) is an emerging
technique for the selective detection of biomolecules such as
peptides, proteins and nucleic acids.1–3 The advantages of SERS
as a labeling/read-out approach include its reduced suscepti-
bility to photobleaching, narrow vibrational Raman bands for
spectral multiplexing, and high sensitivity.4–6 SERS immunoas-
says are apotential alternative to enzyme-linked immunosorbent
assays (ELISA). Their capability for sensitive and multiplexed
protein detection has been demonstrated by Porter and co-
workers7–11 and Ozaki and co-workers.12–14 A typical SERS
immunoassay for protein detection is based on the sandwich
immunocomplex, in which the capture antibodies are immobi-
lized on a substrate such as glass coated with a thin gold lm8–10
and magnetic beads/nanoparticles.15,16 The corresponding
antigen is captured from the sample solution and detected via
the characteristic Raman spectrum of the SERS-labeled detec-
tion antibody aer the formation of the sandwich. Quantitative
information is obtained from concentration-dependent SERS
experiments. The sensitivity and the reproducibility of SERS-u¨ck, Barbarastraße 7, 49069 Osnabru¨ck,
.de
SI) available: Additional information as
c
1based assays are strongly dependent on the quality of the SERS
labels in terms of signal strength and colloidal stability. Porter
and co-workers have introduced SERS labels for protein detec-
tion comprising gold nanoparticles (Au-NPs) coated with a self-
assembled monolayer (SAM) of arylthiols as Raman reporter
molecules (Fig. 1A). A SAM offers the advantages of a maximum
coverage of Raman label molecules on the metal surface, mini-
mized co-adsorption of other molecules from the environment
on the metal surface, and a uniform molecular orientation with
respect to the surface normal for uniform Raman signal
enhancement.7–11 Potential drawbacks of this approach are that
the colloidal stability depends on the particular type of Raman
reporter molecule; terminal charges, for instance, are benecial
for preventing aggregation via electrostatic repulsion between
colloidal particles. Further, a reduced sterical accessibility for
the conjugation of large biomolecular ligands is a direct conse-
quence of thedensepacking of theRaman labelswithin the SAM.
The rationally designed SERS labels depicted in Fig. 1B overcome
both limitations. Monoethylene glycol spacers with a terminal
hydroxyl group (MEG–OH) and triethylene glycol spacers with a
terminal carboxyl group (TEG–CO2H) for subsequent bio-
conjugation are covalently bound to an arylthiol as the actual
Raman reporter moiety (Scheme 1A). Sterical accessibility is
ensured by using an excess (typically 100 : 1 or 1000 : 1) of the
Raman label–spacer conjugate with the shorter MEG–OH spacer
(Fig. 1B and Scheme 1A).17–20 The benets of usingMEG–OH andThis journal is ª The Royal Society of Chemistry 2013
Scheme 1 (A) Synthesis of hydrophilically stabilized Au/Ag-NS labeled with
antibodies; and (B) a sandwich SERS immunoassay platform for IL-6 detection.
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View Article OnlineTEG–CO2H as hydrophilic spacers attached to aromatic Raman
labels include the increased stability of the SERS labels due to the
EG termini and the controllable bioconjugation via the MEG–
OH/TEG–CO2H stoichiometry, together with the advantages of a
SAM (maximum surface coverage with Raman reporters,
uniform molecular orientation, and minimal coadsorption of
other molecules from the surrounding onto the metal surface).
SERS immunoassays have been reported for the detection of
cell surface antigens,21 immunoglobulin G (IgG),8,13 protein A,22
prostate-specic antigen (PSA)9 and proteins against bacteria.23
Cytokines are a diverse group of lowmolecular weight (generally
<20 kDa) proteins, which are involved in a broad spectrum of
biological functions. These functions include mediation or
regulation of immune-responses.24,25 Since these powerful
regulatory and communication molecules are involved in the
pathogenesis of disease, there is an increased demand for their
detection at clinically relevant concentrations.25 For example,
Graham and co-workers achieved the sensitive detection of
tumor necrosis factor a (TNF-a) with resonance Raman (RR)
spectroscopy.26 In the present study, interleukin-6 (IL-6) was
chosen as a representative cytokine target because it is an
inammatory cytokine relevant to many disease processes27
such as diabetes,28 Alzheimer's disease,29 prostate cancer30 and
rheumatoid arthritis.31 It has been reported that advanced/
metastatic cancer patients have higher median levels of IL-6 in
their blood (14.8 pg mL1 vs. 3.7 pg mL1).32 The detection limit
for IL-6 using conventional ELISA is about 18.7 pg mL1,33
which does not meet the requirements of clinical diagnostics.
Improved detection limits have been reported for uorescence34
and surface plasmon resonance (SPR) sensing.35 SERS, however,
offers the additional unique spectral multiplexing advantage.
In this contribution, we employ hydrophilically stabilized
Au/Ag-NS as rationally designed SERS labels (Fig. 1B) for the
sensitive and reproducible detection of IL-6, using a sandwich
immunoassay on functionalized glass slides in combination
with a spatially resolved microspectroscopic detection scheme.
The stability of the hydrophilic SERS labels was investigated
under different physiologically relevant conditions including
high salt concentrations and compared to metal colloids
without terminal EG spacers conjugated to the SAM. The lowestFig. 1 Schematic illustration of SERS labels comprising Au-NPs coated with a
SAM of Raman reporter molecules (A) and hydrophilically stabilized Au/Ag-NS (B).
This journal is ª The Royal Society of Chemistry 2013detectable concentration of IL-6 using the hydrophilically
stabilized Au/Ag-NS is compared with that using hydrophilically
stabilized, nonaggregated solid quasi-spherical Au-NPs of the
same size.Experimental
Reagents
5,50-Dithiobis(2-nitrobenzoic acid) (DTNB), N-(3-dimethyl-ami-
nopropyl)-N0-ethyl-carbodiimide (EDC), N-hydroxy-sulfosucci-
nimide sodium salt (s-NHS), AgNO3, and HAuCl4 were
purchased from Sigma/Aldrich/Fluka. NaHCO3, NaCl,
Na2HPO4, KH2PO4, sodium acetate hydrate, ethanol, anhydrous
ethylene glycol, polyvinylpyrrolidone (PVP), bovine serum
albumin (BSA), tris (tris(hydroxymethyl)aminomethane) and
HEPES (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid)
were purchased from Carl Roth, Germany. Covalent conjuga-
tion of DTNB to a short monoethylene glycol (MEG–OH) and a
longer triethylene glycol moiety (TEG–CO2H) group was
synthesized according to our previous report.18 Monoclonal
anti-human IL-6 antibody (MAB2061), human IL-6 affinity
puried polyclonal antibody (AF-206-NA) and recombinant
human IL-6 (206-IL-010) were purchased from R&D systems Inc.
PBS buffer with pH ¼ 7.4 was prepared according to standard
protocols, using 137 mM NaCl, 2.7 mM KCl, 10 mM Na2H-
PO4$2H2O and 2.0 mM KH2PO4.Preparation of antibody–SERS label conjugates
Au/Ag-NS were prepared based on the template-engaged
replacement reaction between silver nanoparticles and HAuCl4
according to the method reported by Xia and co-workers.36,37 Au-
NPs with the same size (60 nm) were purchased from BBI. As-
prepared Au/Ag-NS and Au-NPs were incubated with Raman
reporters (DTNB–MEG–OH : DTNB–TEG–CO2H ¼ 100 : 1) atAnalyst, 2013, 138, 1764–1771 | 1765
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View Article Onlineroom temperature (RT) under shaking for several hours to form
the corresponding SAM on the metal surface as depicted in
Scheme 1A. Aer incubation, the SAM-coated Au/Ag-NS and Au-
NPs were centrifuged at 1920 g for 15 min and then re-dispersed
into 500 mL of HEPES buffer (pH¼ 5.9). Aerwards, the carboxyl
groups of the SERS labels (TEG–CO2H) were activated by EDC/s-
NHS (40 mL, 5 mg/1.5 mL EDC and 40 mL, 3 mg/1.5 mL s-NHS) in
HEPES buffer at RT for 20 min under shaking. The SERS labels
were then centrifuged to remove excess EDC/s-NHS and re-
dispersed into 500 mL of HEPES buffer. 0.5 mg of polyclonal
antibody (PAb) was then added to 500 mL of colloid containing
activated SERS label suspension for reacting at RT for 1 h and at
4 C overnight for the formation of antibody–SERS label conju-
gates. The maximum number of antibodies bound to the Au/Ag-
NS surface was roughly estimated to be ca. 415 per nanoshell.14
Then 400 mL of TT (Tris–Tween 20)-0.2% BSA buffer was added
into 500 mL of suspension with SERS-labeled antibodies for
reacting at RT for 15–20 min under shaking to block the particle
surface from minimizing non-specic binding. Aer the reac-
tion, the SERS-labeled antibodies were washed three times with
TT-0.2% BSA buffer and centrifuged at 1920 g for 15 min at 6 C.
Then the SERS-labeled antibodies were re-dispersed into 500 mL
of TT-0.2%BSAbuffer and used for binding to the functionalized
glass surface. The bioconjugation of antibodies to the SERS
labels was tested by ELISA using amousemonoclonal secondary
antibody toGoat IgG-FcHRP (ab99710 fromAbcam) labeledwith
HRP (horseradish peroxidase). The enzyme substrate was o-
phenylenediamine dihydrochloride (OPD). The absorbance of
the colored reaction product was detected at 492 nm with a
microplate reader (Sunrise, TECAN. Ltd) aer the enzymatic
reaction was stopped with 3 M H2SO4.Sandwich assay on HD glass slides
The SERS immunoassay platform is shown in Scheme 1B. High
density (HD) TRIDIA (SurModics. Co) glass slides (see ESI,
Fig. S2†) were used as the substrate for immobilization of the
capture antibody. 16 separate compartments (see Scheme 1B)
were generated by covering the functionalized glass surface with
a structured, exible polymer cover (Flexwell, Grace Bio-Labs
Inc.). The concentrations of the monoclonal antibody on the
glass slide for binding were optimized to be 2 mg mL1
according to the activity of HRP determined with a microplate
reader (see above). The HD glass surface was incubated with
80 mL of 2 mg mL1 monoclonal antibody dissolved in carbonate
buffer I (CBI) buffer (0.2 M NaHCO3 and 0.5 M NaCl with
pH¼ 8.5) at RT for 1 h and 4 C overnight. The glass surface was
washed (vortexed) with carbonate buffer II (CBII) buffer (0.1 M
NaHCO3 and 0.5 M NaCl with pH ¼ 8.0) three times, acetate
buffer (AB) (0.1 M sodium acetate with pH¼ 4.4) once and PBST
buffer (PBS with 0.05% Tween 20, pH ¼ 7.4) once. Then the
glass slides were blocked by 2% BSA solution at RT for 2 h to
minimize nonspecic binding. The slides were then washed
(vortexed) with PBST three times. Aer that, different concen-
trations of antigen ranging from 0 pg mL1 to 1 mg mL1 or
2% BSA, 2% casein and 1 mM protein G as negative controls
were incubated with the glass slide at RT for 1 h and then kept at1766 | Analyst, 2013, 138, 1764–17714 C overnight. The glass slides were washed three times again
with PBST buffer and then incubated with SERS-labeled anti-
bodies at RT for 1 h and at 4 C overnight. The concentration of
SERS labels added for incubation was normalized each time
to the optical density of the colloid to ensure reproducibility.
Aerwards, the glass slides were washed three times with PBST
and dried under a nitrogen atmosphere for the measurement.Instrumentation
Au/Ag-NS were characterized by transmission electron micros-
copy (TEM) (Zeiss, EM 902) and UV-Vis extinction spectroscopy
(Perkin Elmer, Lambda 35). SERS spectra were recorded with a
WITec alpha 300 R microspectrometer. The 632.8 nm line from
a HeNe laser was used for excitation of Raman scattering. SERS
images and spectra were obtained at 2 s integration time with
6 mW laser output power by mapping an area of 100 mm 
100 mm (20 pixel  20 pixel) using a 50 microscopy objective
(N.A. ¼ 0.75). A silicon wafer was used for calibration by
checking the laser power at the sample and the focusing
conditions based on the Raman intensity of the rst-order
phonon peak of silicon at ca. 520 cm1.Results and discussion
Characterization of antibody–SERS label conjugates
Au/Ag-NS were prepared based on the template-engaged
replacement reaction between silver nanoparticles and an
aqueous solution of HAuCl4 according to the procedure
described by Xia and co-workers.36,37 Their plasmon peak was
tuned to 630 nm for efficient SERS enhancement upon red
laser excitation.17,38 The as-prepared Au/Ag-NS were character-
ized by transmission electron microscopy (TEM) and extinction
spectroscopy as shown in Fig. 2A and B, respectively. Their
diameter is about60 nm and the corresponding plasmon peak
is located at 628 nm. Scheme 1A depicts the synthesis of SERS-
labeled antibodies starting from Au/Ag-NS. The modied
Raman reporters Ra1 and Ra2 were obtained by covalent
conjugation of monoethylene glycol (MEG–OH) and triethylene
glycol (TEG–CO2H) moieties to the nitro aromatic disulde, 5,50-
dithiobis(2-nitrobenzoic acid) (DTNB). The hydrophilic stabili-
zation approach enhances the water solubility of the noble
metal colloid coated with a SAM of Ra1 and Ra2. This stabili-
zation is independent of the actual Ra precursor and, more
importantly, allows the subsequent conjugation with biomole-
cules aer activation of the carboxyl group at the terminus of
the longer spacer moiety (TEG–CO2H) in Ra2. A stoichiometric
ratio of Ra1 : Ra2 ¼ 100 : 1 was chosen to ensure the steric
accessibility of the carboxyl groups in the densely packed
SAM.19,20,39 The addition of DTNB–MEG–OH (Ra1) and DTNB–
TEG–CO2H (Ra2) to the metal colloid leads to a hydrophilically
stabilized self-assembled monolayer comprising two different
terminal spacer units (dual spacer-SAM, cf. Fig. 1B). The pres-
ence of a close and dense packing of Raman reporter molecules
within the SAM on the metal surface minimizes the co-
adsorption of other molecules from the surrounding onto the
metal surface (no spectral interference) and ensures theThis journal is ª The Royal Society of Chemistry 2013
Fig. 2 TEM image (A), extinction spectrum (B) and SERS spectrum (C) of hydrophilically stabilized Au/Ag-NS.
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View Article Onlinemaximum coverage of the metal surface with Raman reporter
molecules (high sensitivity).18,40 The carboxyl groups in the SAM
on the surface of the Au/Ag-NS are activated by EDC/s-NHS for
bioconjugation to antibodies. The bioconjugation step was
conrmed and optimized by ELISA using an enzyme-labeled
antibody (see the Experimental part for details). The SERS
spectrum of the hydrophilically stabilized colloid (Fig. 2C)
obtained upon red laser excitation (633 nm) exhibits a domi-
nant peak at 1334 cm1, which is assigned to the symmetric
stretching vibration of the nitro moiety in the nitro aromatic
thiol.18,19 The plasmon peak of the Au/Ag-NS exhibits a red-shi
from 628 nm to 633 nm aer coating with the SAM and further
to 636 nm aer EDC/s-NHS activation and bioconjugation to the
antibody (Fig. S1A†). The similarity of the SERS spectra recordedFig. 3 Stability comparison between SERS labels with (A) and without a hydrophi
This journal is ª The Royal Society of Chemistry 2013aer each functionalization step (Fig. S1B†) demonstrates the
stability of the SERS NPs, in particular the stability of the SAM
on the metal surface.Stability of SERS labels under physiologically relevant
conditions
High stability of SERS labels under physiologically relevant
conditions is a necessary prerequisite for their successful
application in bioanalytical chemistry. We therefore tested the
stability of SAM-coated metal colloids against aggregation in
various dispersion media. The extinction spectra in Fig. 3A
indicate that hydrophilically stabilized SERS particles coated
with Ra1 (MEG–OH) are stable in water, HEPES buffer and evenlically spacer (MEG–OH) conjugated to the Raman reporter moiety (B).
Analyst, 2013, 138, 1764–1771 | 1767
Fig. 4 Typical SERS false-color images recorded for different IL-6 concentrations ranging from 0 to 10 ng mL1 using integrated Raman intensities in the range
between 1330 and 1350 cm1.
Analyst Paper
Pu
bl
ish
ed
 o
n 
18
 Ja
nu
ar
y 
20
13
. D
ow
nl
oa
de
d 
by
 U
ni
ve
rs
ity
 o
f Q
ue
en
sla
nd
 on
 08
/10
/20
15
 07
:13
:40
. 
View Article Onlinein PBS buffer with high ionic strength (13.7 mM NaCl). In
contrast, SERS labels without hydrophilic stabilization (no
MEG–OH terminal in Ra1) appear to be slightly aggregated in
HEPES (50 mM) buffer and more strongly aggregated in water.
The aggregation was worse in PBS buffer with 13.7 mM NaCl.
Overall, these results demonstrate that the ethylene glycol
spacer unit conjugated to the arylthiol as the actual Raman
reporter moiety signicantly increases the stability of SERS
labels under physiologically relevant conditions, i.e., buffer
solutions with high ionic strength.Fig. 5 SERS spectra for IL-6 detection at different concentrations. The SERS
spectrum was obtained by the average of 2000 individual spectra in the SERS
mapping.Detection of IL-6 using immuno-SERS microspectroscopy
Scheme 1B shows the procedure of the sandwich SERS immu-
noassay platform for IL-6 detection. Functionalized glass slides
(cf. also Fig. S2†) were used for immobilizing the capture anti-
body. Sixteen different wells (reaction chambers/compart-
ments) per glass slide were obtained by putting a commercially
available polymer cover (photograph displayed in Scheme 1B).
Eight pairs of wells were used for concentration-dependent
SERS studies (C0–C5) including negative control experiments
(BSA and casein). Aer blocking the surface with 2% BSA in
PBST, the antigen (IL-6) is immobilized by specic binding to
the capture antibody. Finally, the SERS-labeled detection anti-
body specically recognizes the antigen at a different epitope,
thereby forming the immuno-sandwich complex. Achieving
reproducible data for biomolecular detection by SERS can be
challenging due to the non-uniform spatial distribution of SERS
nanoparticles on the surface.41 This can be circumnavigated by
averaging over SERS spectra recorded from different locations
on the substrate.9,10,38,42,43 However, this approach is usually
limited to only a few positions which are arbitrarily chosen. In
our study, a spatially resolved microspectroscopic SERS detec-
tion scheme (confocal Raman point mapping) is employed as
the read-out method in order to obtain highly representative
SERS spectra due to spatial averaging over larger areas
including many pixels. Fig. 4 displays typical SERS false-color
images using the integrated Raman intensity of the nitro moiety
band of the Raman reporters between 1330 cm1 and 1350
cm1 in an area of 100 mm  100 mm. For each IL-6 concen-
tration in the range of 0–10 ng mL1 (Fig. 4), two reaction1768 | Analyst, 2013, 138, 1764–1771chambers were analyzed (cf. Scheme 1B) by covering an area of
100 mm  100 mm (20  20 ¼ 400 pixels). Upon increasing the
IL-6 concentration, more SERS-labeled detection antibodies
bind to the glass surface, and consequently, a higher SERS
intensity is detected, which is reected in the brighter false-
color SERS images. The SERS false-color images (Fig. 4) in
combination with SEM images (Fig. S3†) indicate that it is
difficult to achieve a very homogeneous distribution of the SERS
nanoparticles on the surface, even though the fabrication and
aggregation conditions of the hydrophilically stabilized colloid
have been carefully controlled. Without the target antigen, only
a very few single particles are observed, probably due to
nonspecic binding, while at 100 pg mL1 IL-6 more SERS
particles are observed on the glass surface with slight aggrega-
tion (Fig. 4 and S3†). These observations stress the importance
of averaging the SERS signal over larger areas instead of arbi-
trarily selecting only a few positions for signal acquisition.44
(a) Reproducibility and sensitivity of the IL-6 SERS immu-
noassay. To test the reproducibility of the SERS immunoassay,
repeated experiments were conducted as shown in Figs. S4 and
S5†. SERS false-color images and average SERS spectra for 1 ng
mL1 IL-6 were compared on the same day (Fig. S4†) andThis journal is ª The Royal Society of Chemistry 2013
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View Article Onlinedifferent days (Fig. S5†). Thus, average SERS spectra were
analyzed based on these images (thousands of points, indi-
vidual spectra) as indicated in Fig. 5. The concentration-
dependent SERS response curve in Fig. 6 is based on the average
SERS spectra for each concentration in the range of 1 pg mL1
to 1 mg mL1. Again, the integrated Raman intensity of the band
around 1334 cm1 from the Raman reporter was used for
generating image contrast. The lowest detectable concentration
for IL-6 is ca. 1 pg mL1, which is one to two orders more
sensitive than the conventional ELISA.33
(b) Selectivity of the IL-6 SERS immunoassay. Specicity is
also a very important feature of an immunoassay. In this study,Fig. 8 SERS intensity (A) and average SERS spectrum (B) for the IL-6 sandwich imm
Fig. 6 Average SERS intensity as a function of IL-6 concentration detection in the
range from 1 pg mL1 to 1 mg mL1.
Fig. 7 SERS intensity (A) and average SERS spectrum (B) for testing the specificity
This journal is ª The Royal Society of Chemistry 20132% BSA, 2% casein and 1 mM protein G (much higher concen-
tration than the target antigen) instead of IL-6 were used for
negative control experiments. The diagram and average SERS
spectra in Fig. 7 indicate only very weak SERS signals for BSA,
casein and protein G, demonstrating the high specicity of the
SERS immunoassay. Additional negative control experiments
using SERS-labeled BSA and SERS-labeled antibodies directed
against interleukin 8 (IL-8) were performed. Low SERS intensi-
ties are observed, similar to those observed in the absence of IL-
6 (0 pg mL1), indicating nonspecic protein binding (BSA) and
low cross reacting with a similar target (IL-8).
(c) Comparing the sensitivity for Au/Ag-NS to solid quasi-
spherical Au-NPs. Solid quasi-spherical gold nanoparticles (Au-
NPs) with the same diameter as the Au/Ag-NS (60 nm) were
employed in the same sandwich immunoassay platform for
comparing their performance as plasmonic materials for SERS
detection. The same protocols for bioconjugation, incubation
and SERS microspectroscopic mapping used for Au/Ag-NS were
also applied for IL-6 detection with Au-NPs. Using the SERS
false-color images obtained at different IL-6 concentrations
(Fig. S6†), the SERS intensity vs. IL-6 concentration diagram in
Fig. 8A was constructed. Based on the SERS response curve in
Fig. 8, the lowest detectable concentration is ca. 10–100 pg
mL1, which is one to two orders of magnitude worse compared
with the Au/Ag-NS. This is due to the higher scattering efficiency
of Au/Ag-NS compared with Au-NPs.14 The extinction spectra in
Fig. S7† contain the sum of both scattering and absorption
contributions and exhibit plasmon peaks at 540 nm (Au-NPs)unoassay using solid quasi-spherical Au-NPs.
of the IL-6 sandwich immunoassay using Au/Ag-NS.
Analyst, 2013, 138, 1764–1771 | 1769
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View Article Onlineand 628 nm (Au/Ag-NS), respectively. The green line in Fig. S8†
shows the laser excitation wavelength used in this study (633
nm), while the blue line indicates the Stokes–Raman wave-
length corresponding to themarker band of the Raman reporter
at 1334 cm1 (691 nm).45 Since the Stokes-SERS intensity is
strongly dependent on the scattering cross-sections at the
wavelength of both the incident laser and the Stokes–Raman
scattering, it was calculated that the enhancement of Au/Ag-NS
is about 20 times larger than that for Au-NPs at red laser exci-
tation (633 nm).17 Our experimental nding of the improved
SERS sensitivity of Au/Ag-NS compared with Au-NPs in an IL-6
SERS immuno-sandwich assay conrms this theoretical
prediction.Conclusions
In the present study, rationally designed Au/Ag-NS were
employed as SERS labels for the sensitive and selective detec-
tion of the cytokine IL-6. The Raman reporter moieties were
conjugated to ethylene glycol spacers with terminal OH and
CO2H groups and are present as a SAM on a nanoshell surface.
This hydrophilically stabilized dual-spacer SAM on Au/Ag-NS
exhibits a high stability, even under physiologically relevant
conditions such as buffer solutions with high ionic strength.
The hydrophilically stabilized colloid does not precipitate,
while the non-stabilized colloid precipitate. The lowest detect-
able concentration for IL-6 is ca.1 pg mL1 with Au/Ag-NS,
which is at least one order of magnitude better than for
hydrophilically stabilized, nonaggregated solid Au-NPs of the
same size. Owing to the high signal strength and specicity for
IL-6 detection with these rationally designed plasmonic nano-
structures for red laser excitation, it is expected that the detec-
tion of IL-6 also in human samples such as plasma and blood
samples for clinical diagnostics can be achieved, preferably with
portable Raman instrumentation.Acknowledgements
Financial support from the Alexander von Humboldt Founda-
tion, the State of Lower Saxony (EFRE/W2-80111700), and the
German Research Foundation (DFG, INST 190/128-1) is
acknowledged.References
1 D. Graham, K. Faulds and W. E. Smith, Chem. Commun.,
2006, 42, 4363–4371.
2 W. E. Doering, M. E. Piotti, M. J. Natan and R. G. Freeman,
Adv. Mater., 2007, 19, 3100–3108.
3 S. Schlu¨cker, in Surface-Enhanced Raman Spectroscopy:
Analytical, Biophysical and Life Science Applications, ed. S.
Schlu¨cker, Wiley-VCH, Weinheim, Germany, 2011, pp. 263–
283.
4 Y. C. Cao, R. C. Jin, J. M. Nam, C. S. Thaxton and C. A. Mirkin,
J. Am. Chem. Soc., 2003, 125, 14676–14677.
5 Y. W. C. Cao, R. C. Jin and C. A. Mirkin, Science, 2002, 297,
1536–1540.1770 | Analyst, 2013, 138, 1764–17716 D. Graham, B. J. Mallinder, D. Whitcombe, N. D. Watson and
W. E. Smith, Anal. Chem., 2002, 74, 1069–1074.
7 M. D. Porter, R. J. Lipert, L. M. Sioperko, G. Wang and
R. Narayanan, Chem. Soc. Rev., 2008, 37, 1001–1011.
8 J. Ni, R. J. Lipert, G. B. Dawson and M. D. Porter, Anal. Chem.,
1999, 71, 4903–4908.
9 D. S. Grubisha, R. J. Lipert, H. Y. Park, J. Driskell and
M. D. Porter, Anal. Chem., 2003, 75, 5936–5943.
10 G. F. Wang, R. J. Lipert, M. Jain, S. Kaur, S. Chakraboty,
M. P. Torres, S. K. Batra, R. E. Brand and M. D. Porter,
Anal. Chem., 2011, 83, 2554–2561.
11 G. F. Wang, H. Y. Park, R. J. Lipert and M. D. Porter, Anal.
Chem., 2009, 81, 9643–9650.
12 S. Xu, X. Ji, W. Xu, X. Li, L. Wang, Y. Bai, B. Zhao and
Y. Ozaki, Analyst, 2004, 129, 63–68.
13 X. X. Han, Y. Kitahama, T. Itoh, C. X. Wang, B. Zhao and
Y. Ozaki, Anal. Chem., 2009, 1, 3350–3355.
14 X. X. Han, B. Zhang and Y. Ozaki, Anal. Bioanal. Chem., 2009,
394, 1719–1727.
15 M. E. Pekdemir, D. Ertu¨rkan, H. Ku¨lah, I. H. Boyaci, C. Ozgen
and U. S. Tamer, Analyst, 2012, 137, 4834–4840.
16 B. Guven, N. Basaran-Akgul, E. Temur, U. Tamer and
I. H. Boyaci, Analyst, 2011, 136, 740–748.
17 B. Ku¨stner, M. Gellner, M. Schu¨tz, F. Scho¨ppler, A. Marx,
P. Stro¨bel, P. Adam, C. Schmuck and S. Schlu¨cker, Angew.
Chem., Int. Ed., 2009, 48, 1950–1953.
18 C. Jehn, B. Ku¨stner, P. Adam, A. Marx, P. Stro¨bel, C. Schmuck
and S. Schlu¨cker, Phys. Chem. Chem. Phys., 2009, 11, 7499–
7504.
19 S. Schlu¨cker, M. Salehi, G. Bergner, M. Schu¨tz, P. Strobel,
A. Marx, I. Petersen, B. Dietzek and J. Popp, Anal. Chem.,
2011, 83, 7081–7085.
20 M. Schu¨tz, D. Steinigeweg, M. Salehi, K. Ko¨mpe and
S. Schlu¨cker, Chem. Commun., 2011, 47, 4216–4218.
21 B. J. Yakes, R. J. Lipert, J. P. Bannantine and M. D. Porter,
Clin. Vaccine Immunol., 2008, 15, 227–234.
22 J. L. Gong, Y. Liang, Y. Huang, J. W. Chen, J. H. Jiang,
G. L. Shen and R. Q. Yu, Biosens. Bioelectron., 2007, 22,
1501–1507.
23 K. Chen, H. Han and Z. Luo, Analyst, 2012, 137, 1259–1264.
24 R. Thorpe, M. Wadhwa, C. R. Bird and A. R. Mire-Sluis, Blood
Rev., 1992, 6, 133–148.
25 T. L. Whiteside, J. Clin. Immunol., 1994, 14, 327–339.
26 S. Laing, A. Hernandez-Santana, J. Sassmannshausen,
D. L. Asquith, I. B. McInnes, K. Faulds and D. Graham,
Anal. Chem., 2011, 83, 297–302.
27 Y. Dowlati, N. Herrmann, W. Swardfager, H. Liu, L. Sham,
E. K. Reim and K. L. Lanctot, Biol. Psychiatry, 2010, 67,
446–457.
28 O. P. Kristiansen and T. Mandrup-Poulsen, Diabetes, 2005,
54, S114–124.
29 W. Swardfager, K. Lanctoˆt, L. Rothenburg, A. Wong,
J. Cappell and N. Herrmann, Biol. Psychiatry, 2010, 68,
930–941.
30 P. C. Smith, A. Hobisch, D. L. Lin, Z. Culig and E. T. Keller,
Cytokine Growth Factor Rev., 2001, 12, 33–40.
31 N. Nishimoto, Curr. Opin. Rheumatol., 2006, 18, 277–281.This journal is ª The Royal Society of Chemistry 2013
Paper Analyst
Pu
bl
ish
ed
 o
n 
18
 Ja
nu
ar
y 
20
13
. D
ow
nl
oa
de
d 
by
 U
ni
ve
rs
ity
 o
f Q
ue
en
sla
nd
 on
 08
/10
/20
15
 07
:13
:40
. 
View Article Online32 CancerPatientsTypicallyHave Increased Interleukin-6Levels.
American Society of Clinical Oncology 2006 Annual Meeting,
Abstracts 8632 and 8633, http://Medscape.com, 2006-06-26.
33 ELISA kit for IL-6 detection, http://www.sinobiological.com/
IL6-IFNB2-ELISA-kit-g-2677.html.
34 W. Tan, L. Sabet, Y. Li, T. Yu, P. R. Klokkevold, D. T. Wong
and C. M. Ho, Biosens. Bioelectron., 2008, 24, 266–271.
35 T. Yamaguchi, T. Kaya, M. Aoyama and H. Takei, Analyst,
2009, 134, 776–783.
36 Y. G. Sun, B. T. Mayers and Y. N. Xia, Nano Lett., 2002, 2, 481–
485.
37 Y. Sun and Y. Xia, Anal. Chem., 2002, 74, 5297–5305.
38 S. W. Bishnoi, Y. J. Lin, M. Tibudan, Y. Huang, M. Nakaema,
V. Swarup and T. A. Keiderling, Anal. Chem., 2011, 83, 4053–
4060.This journal is ª The Royal Society of Chemistry 201339 M. Schu¨tz, C. Mu¨ller, M. Salehi, C. Lambert and S. Schlu¨cker,
J. Biophotonics, 2011, 6, 453–463.
40 M. Gellner, K. Ko¨mpe and S. Schlu¨cker, Anal. Bioanal. Chem.,
2009, 394, 1839–1844.
41 R. A. Tripp, R. A. Dluhy and Y. Zhao, Nano Today, 2008, 3, 31–
37.
42 C. C. Lin, Y. M. Yang, Y. F. Chen, T. S. Yang and H. C. Chang,
Biosens. Bioelectron., 2008, 24, 178–183.
43 C. Song, S. Z. Wang, R. Zhang, J. Yang, X. Tang and Y. Cui,
Biosens. Bioelectron., 2009, 25, 826–831.
44 M. Lee, S. Lee, J. Lee, H. Lim, G. H. Seong, E. K. Lee,
S. Chang, C. H. Oh and J. Choo, Biosens. Bioelectron., 2011,
26, 2135–2141.
45 M. Gellner, B. Ku¨stner and S. Schlu¨cker, Vib. Spectrosc., 2009,
50, 43–47.Analyst, 2013, 138, 1764–1771 | 1771
